Literature DB >> 8829716

Antipsychotic drug-induced dysphoria.

D J King1, M Burke, R A Lucas.   

Abstract

BACKGROUND: Dysphoric reactions to antipsychotic medication are well recognised in association with akathisia, but can also occur independently.
METHOD: Fifty-one healthy volunteers were given haloperidol 5 mg in two consecutive pharmacokinetic studies.
RESULTS: Dysphoria occurred in about 40% of the subjects on both occasions, but akathisia was only detected in 8% (first study) and 16% (second study). All adverse effects were transient and were abolished in nine of the ten subjects given procyclidine.
CONCLUSIONS: While dysphoria is a well-recognized reaction in healthy volunteers, it is probably insufficiently recognised in patients, particularly if it occurs in the absence of akathisia. Better detection could improve compliance in patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8829716     DOI: 10.1192/bjp.167.4.480

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

Review 1.  Delirium and cognitive dysfunction in the intensive care unit.

Authors:  Russell R Miller; E Wesley Ely
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 5.285

2.  Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

Authors:  T D Irons; P E Kelly; D L Hunter; R C Macphail; S Padilla
Journal:  Pharmacol Biochem Behav       Date:  2012-12-28       Impact factor: 3.533

Review 3.  Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence.

Authors:  Hanjing Emily Wu; Olaoluwa O Okusaga
Journal:  Psychiatr Q       Date:  2015-06

4.  Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.

Authors:  Sarah A Eisenstein; Ryan Bogdan; Ling Chen; Stephen M Moerlein; Kevin J Black; Joel S Perlmutter; Tamara Hershey; Deanna M Barch
Journal:  J Psychiatr Res       Date:  2016-11-17       Impact factor: 4.791

5.  Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change.

Authors:  E T C Ngan; C J Lane; T J Ruth; P F Liddle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

6.  Disruption of conditioned reward association by typical and atypical antipsychotics.

Authors:  C L Danna; G I Elmer
Journal:  Pharmacol Biochem Behav       Date:  2010-04-21       Impact factor: 3.533

7.  Olanzapine vs haloperidol: treating delirium in a critical care setting.

Authors:  Yoanna K Skrobik; Nicolas Bergeron; Marc Dumont; Stewart B Gottfried
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

Review 8.  Pharmacological control of acute agitation: focus on intramuscular preparations.

Authors:  Dan L Zimbroff
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Primary care use of antipsychotic drugs: an audit and intervention study.

Authors:  Ann M Mortimer; Charles J Shepherd; Michael Rymer; Alison Burrows
Journal:  Ann Gen Psychiatry       Date:  2005-11-29       Impact factor: 3.455

10.  A road less travelled by. A review lecture given to the Royal Irish Academy on the occasion of the Award of Merit and Silver Medal by the Consultative Committee for Pharmacology & Toxicology on 22 November 2001.

Authors:  David J King
Journal:  Ulster Med J       Date:  2003-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.